Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: CD36 promotes vasculogenic mimicry in melanoma by mediating adhesion to the extracellular matrix

Fig. 1

Association of clinical outcome in melanoma patients with high CD36 expression. (A) Patient data accessed from the TCGA-SKCM project (n = 470) was categorized into the top and bottom 10% of CD36 gene expression (CD36-high (red) and CD36-low (black), respectively), ****p < 0.0001, unpaired t-test. (B) From the data in A, a Kaplan-Meier analysis was conducted between the CD36-high and CD36-low populations (n = 47 per group)

Back to article page